Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

492 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH, Shiu SW, Leng L, Bucala R, Betteridge DJ, Tan KC. Tam XH, et al. Clin Sci (Lond). 2011 Jan;120(2):81-9. doi: 10.1042/CS20100256. Clin Sci (Lond). 2011. PMID: 20726839
Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Tan KC, et al. Diabetologia. 2006 Nov;49(11):2756-62. doi: 10.1007/s00125-006-0394-1. Epub 2006 Sep 13. Diabetologia. 2006. PMID: 16969649
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity.
Teismann P, Sathe K, Bierhaus A, Leng L, Martin HL, Bucala R, Weigle B, Nawroth PP, Schulz JB. Teismann P, et al. Neurobiol Aging. 2012 Oct;33(10):2478-90. doi: 10.1016/j.neurobiolaging.2011.12.006. Epub 2012 Jan 9. Neurobiol Aging. 2012. PMID: 22227007 Free PMC article.
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Alban TJ, Bayik D, Otvos B, Rabljenovic A, Leng L, Jia-Shiun L, Roversi G, Lauko A, Momin AA, Mohammadi AM, Peereboom DM, Ahluwalia MS, Matsuda K, Yun K, Bucala R, Vogelbaum MA, Lathia JD. Alban TJ, et al. Among authors: leng l. Front Immunol. 2020 Jun 18;11:1191. doi: 10.3389/fimmu.2020.01191. eCollection 2020. Front Immunol. 2020. PMID: 32625208 Free PMC article.
Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
Burger-Kentischer A, Göbel H, Kleemann R, Zernecke A, Bucala R, Leng L, Finkelmeier D, Geiger G, Schaefer HE, Schober A, Weber C, Brunner H, Rütten H, Ihling C, Bernhagen J. Burger-Kentischer A, et al. Atherosclerosis. 2006 Jan;184(1):28-38. doi: 10.1016/j.atherosclerosis.2005.03.028. Atherosclerosis. 2006. PMID: 15921687
Evidence for a role of macrophage migration inhibitory factor in vascular disease.
Chen Z, Sakuma M, Zago AC, Zhang X, Shi C, Leng L, Mizue Y, Bucala R, Simon D. Chen Z, et al. Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):709-14. doi: 10.1161/01.ATV.0000119356.35748.9e. Epub 2004 Jan 29. Arterioscler Thromb Vasc Biol. 2004. PMID: 14751814
Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J. Lue H, et al. Cell Signal. 2006 May;18(5):688-703. doi: 10.1016/j.cellsig.2005.06.013. Epub 2005 Aug 24. Cell Signal. 2006. PMID: 16122907
Role for macrophage migration inhibitory factor in asthma.
Mizue Y, Ghani S, Leng L, McDonald C, Kong P, Baugh J, Lane SJ, Craft J, Nishihira J, Donnelly SC, Zhu Z, Bucala R. Mizue Y, et al. Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14410-5. doi: 10.1073/pnas.0507189102. Epub 2005 Sep 26. Proc Natl Acad Sci U S A. 2005. PMID: 16186482 Free PMC article.
492 results
Jump to page